BELVIQ XR
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

BELVIQ XR Trademark

Serial Number: 86693911 • Registration: 4922297

BELVIQ XR is a trademark filed by Arena Pharmaceuticals GmbH on July 15, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Arena Pharmaceuticals GmbH (74 trademarks)

Untere Bruhlstrasse 4
CH-4800 Zofingen , CH

Entity Type: 99

Trademark Details

Filing Date

July 15, 2015

Registration Date

March 22, 2016

Published for Opposition

January 5, 2016

Cancellation Date

October 7, 2022

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 7, 2022 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 22, 2021 REM1
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Apr 5, 2017 CORV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2017 CRFA
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 30, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2015 CRFA
ASSIGNED TO LIE
Nov 16, 2015 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 28, 2015 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 14, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 14, 2015 GNSL
SUSPENSION LETTER WRITTEN
Oct 14, 2015 CNSL
ASSIGNED TO EXAMINER
Oct 6, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 22, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 21, 2015 NWOS
NEW APPLICATION ENTERED
Jul 18, 2015 NWAP